Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Oesophago-gastric Cancer × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 84 Stomach Neoplasms 51 Rectal Neoplasms 47 Colonic Neoplasms 43 Pancreatic Neoplasms 18 Neoplasms 14 Carcinoma, Hepatocellular 13 Neoplasm Metastasis 12 Lymphoma, Large B-Cell, Diffuse 9 Cholangiocarcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Esophageal Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Lymphoma, Extranodal NK-T-Cell 3 Gallbladder Neoplasms 3 Biliary Tract Neoplasms 3 Neurotoxicity Syndromes 2 Lymphoma 2 Liver Neoplasms 2 Hepatoblastoma 2 Gastrointestinal Neoplasms 2 Gastrointestinal Diseases 2 Colorectal Adenocarcinoma 2 Resectable Colon Cancer 1 Recurrence 1 Rectal Diseases 1 Radiation Injuries 1 Peritoneal Neoplasms 1

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡